Appropriate utilization of the prognostic 40-gene expression profile (40-GEP) test for cutaneous squamous cell carcinoma (cSCC) demonstrated by clinical reports and physician evaluation of real-world cases. (2022). SKIN The Journal of Cutaneous Medicine, 6(2), s21. https://doi.org/10.25251/skin.6.supp.21